Repligen | RGEN - EPS Earnings Per Share


Repligen reported $0.54 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.47 0.46 Nov/03
FY2026Q2 Jun/2026 0.54 0.45 0.37 Jul/28
FY2026Q1 Mar/2026 0.48 0.39 0.39 May/05
FY2025Q4 Dec/2025 0.49 0.44 0.44 Feb/24
FY2025Q3 Sep/2025 0.46 0.42 0.43 Oct/28




Eps Change Date
Agilent USD 1.43 0.11 Mar/2026
Align Technology USD 2.64 0.06 Jun/2026
Bio Techne USD 0.53 0.07 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Bruker USD 0.49 0.18 Jun/2026
Charles River Laboratories USD 3.02 0.96 Jun/2026
Danaher USD 1.94 0.12 Jun/2026
Dentsply International USD 0.27 0.2 Mar/2026
General Electric Aerospace USD 2.02 0.16 Jun/2026
Henry Schein USD 1.27 0.05 Jun/2026
Illumina USD 1.31 0.16 Jun/2026
IQVIA Holdings USD 3.15 0.25 Jun/2026
Mettler Toledo International USD 11.46 2.55 Jun/2026
Myriad Genetics USD -0.25 0.16 Jun/2026
OraSure Technologies USD -0.18 0 Dec/2025
Pacific Biosciences Of California USD -0.17 0.12 Dec/2025
Pfizer USD 0.77 0.02 Jun/2026
Repligen USD 0.54 0.06 Jun/2026
Revvity USD 1.41 0.35 Jun/2026
Standard Biotools USD 0.33 0.29 Mar/2026
Thermo Fisher Scientific USD 6.03 0.59 Jun/2026
Waters USD 3.05 0.35 Jun/2026
West Pharmaceutical Services USD 2.37 0.24 Jun/2026